With many, many thanks to the CEO’s from Zephyr Energy, Power Metal Resources, Scirocco Energy and SpectrumX who entertained and informed us at last night’s investor event. To see their video presentations view here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So much to agree with in this thread. The one phrase that’s important above all is: “ the subscribers are an insurance policy against the big Pharma” - exactly. That’s what’s driving the rise towards 9p and this is what gives the Sarum board strength for any negotiation, be that t/o, licensing or any other deal.
Fantastic CW free posts this weekend, calm before the storm?? Oh and we'll know they will be back ;) SAR at a pivotal point that no body could have predicted, originally all cancer but WHO could have predicted this shower shyte that would that landed and would cripple the world.!! Watched many disaster and horror movies, but Planet Earth deals, and moves on with real life events. (Ice age !) Without a doubt I can see this becoming a blockbuster movie one day.
SARS V's SAR ;)
GLALTH's its been a fantastic voyage, we've nearly landed ;)
Will do Matufa. I especially love the Simply Wall Street post I believe 20th May re unsettling investors re 'cashburn' at Sareum LMFAO! What happened next.....subscriptions..... Gotta love a bit of negative company propaganda from them that makes them look like absolute idiots! Like Motley ! Paid for by shorters imo. I'm having Enchiladas tonight. That you can bank on.
Hi Mafuta. Yes my post 19th July at 1900 hours included the first subscription warrants being exercised re public financial investment. I put a quite detailed post re subscriptions and warrants. Matufa I think we are on the verge of something extraordinary but I might go silent as it would seem 'obvious' posts delay company posts. But I will still keep reading the great posts here.
James ... We have a tree shake every day from 1 pm to 3pm it's a pattern we have been following for a long time now ... It helps thin out the short termers, day traders and uninformed ... But they don't phase the LTH
Danny ... Have you included the amount raised by exercising the warrants into your calculation? .. I agree I ... can see SAR chasing the new fund ... I've mentioned before that I wouldn't be surprised to see another HNWI turn up ... And I get the distinct impression that SAR want to go it alone or with a philanthropic partner to bat off any pharmaceutical predators ... They know if they agree to a merger or T/O with a large pharma it will be goodbye to their compounds as they will be shelved like SRA737 or be messed around like we're were with the Chinese pharma... we do indeed live in interesting times ... I'm glad I'm not out of this one this weekend ... Mafuta
Mafuta. Ditto. Greatly enjoy your posts. I posted on 31st July at 1854 that AZ were looking at other options due to their tie up with Oxford University that their vaccines can only be sold at cost. The earnings Pfizer are making is about 30 times greater than AZs 'revenue' for their vaccine. That was said by Ruud Dobber head of Astras biopharmaceutical unit. So a further pill treatment superior to Dexamethasome....... Investment into Sareum ..... The new subscribers still have £490k warrants that can exercised as we have had above 7p for 5 days. If we see above 9p for 5 days then a further £1m option. Can the primary bid be included in the Agile £5m investment be allowed? Seriously there are so many exciting fundamentals in play it's like Cluedo. Albeit not who killed who but the way we leap forward. It's almost like the subscribers are an insurance policy against the big Pharma imo......for the time being ;-)
Danny ... You might well be right ... I mentioned in a previous post the revenue Pfizer have raked in thus far on their vaccine sales ... Pharmaceuticals are a huge cutthroat market .. there is nothing they wouldn't do to protect their income streams ... Even at the cost of those who suffer ... Watch this space
Top point The Oracle. My opinion. Pharmas and their world is VERY different to the world we live in. What with their lobbying and junkets they provide to those who approve and prescribe their products. So in order to get a seat at the table with a very promising product which would be in direct competition with Dexamethasome would rattle them. The fact ours is superior requires individuals with clout to be aparty to our product in a financial means to make it known on the media platforms. This is where I think the Subscriptions by I believe 2 HNWIs and the timing is beyond coincidence. Some have had a guess at who they might be. Watch this space. I bought above 9p (top up) and you know what? I'm glad I did. Next week might be interesting and a Trading Update RNS is due that will roadmap the future. That's my thought. Regards Steadydanny
"On 01 July, Sareum announced that the proof of concept experiments had been completed and importantly that their kinase inhibitor drug candidate SDC-1801 had reduced the levels of cytokines associated with ARDS in human lung cells infected with SARS-CoV-2 and demonstrated a profile that was considered superior to dexamethasone. This is great news for not only the UK but for the World."
Just been playing on my mind, the aspect of something superior being near enough available, yet no one paying attention during a pandemic. Something must be going on, it's far to quiet from Sareum.